Harmony Biosciences Holdings, Inc.
Harmony Biosciences develops therapies for rare neurological diseases.
SCHEDULE 13GNov 16Latest SEC filing
Nov 4Latest story
November 2026
October 2026
August 2026
July 2026
Harmony Biosciences develops therapies for rare neurological diseases.
November 2026
October 2026
August 2026
July 2026